Oral progestagens before menopause and breast cancer risk
2007

Oral Progestagens and Breast Cancer Risk

Sample size: 73664 publication Evidence: moderate

Author Information

Author(s): Alban Fabre, Anne Fournier, Sophie Mesrine, Jean Desreux, Alain Gompel, Marie-Claude Boutron-Ruault, Francois Clavel-Chapelon

Primary Institution: INSERM (Institut National de la Santé et de la Recherche Médicale)

Hypothesis

Does the use of progestagen-only treatments before menopause increase the risk of breast cancer in women over 40?

Conclusion

The study suggests that prolonged use of progestagens after the age of 40 may be associated with an increased risk of breast cancer.

Supporting Evidence

  • The study included 73,664 women and identified 2,390 cases of invasive breast cancer during follow-up.
  • Current use of progestagens for longer than 4.5 years was significantly associated with an increased risk of breast cancer.
  • No significant association was found between ever-use of progestagens and breast cancer risk overall.

Takeaway

This study looked at whether taking certain hormones called progestagens before menopause can lead to breast cancer in older women. It found that using them for a long time might increase the risk.

Methodology

The study analyzed data from the French E3N cohort, focusing on women over 40 who used progestagens, tracking their breast cancer diagnoses over time.

Potential Biases

Self-reported data on progestagen use may lead to misclassification, but this is expected to be non-differential between cases and non-cases.

Limitations

Details on treatment dosage and frequency were not recorded, which limited the analysis of risk associated with different usage patterns.

Participant Demographics

Women aged 40-64 years from the MGEN health insurance scheme in France.

Statistical Information

P-Value

0.012

Confidence Interval

1.03–2.00

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6603618

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication